REFINANCING – LAUNCH OF AN EXCHANGE OFFER AND CONSENT SOLICITATION
Lyon, France
Novasep Holding S.A.S (“Novasep”), a leading global provider of integrated purification and manufacturing solutions to pharmaceutical and other life science industries, announces the launch of an exchange offer and consent solicitation in order to refinance (the “Refinancing”) its outstanding 8.00% Senior Secured Notes due 2016 in the aggregate principal amount of $195,164,000 (the “Existing Notes”) with the aim of supporting its robust growth plan and development. The Existing Notes are currently listed on the Official List of the Luxembourg Stock Exchange and admitted to trading on the Euro MTF market (ISIN numbers: XS0737680479 / XS0737712181).
Novasep, its majority shareholder, Bpifrance and certain holders of its Existing Notes have agreed to take certain actions in support of the Refinancing. Their agreements include an agreement by certain bondholders holding approximately 75.6% of the Existing Notes (the “Cornerstone Holders”) to tender their Existing Notes in the Exchange

